These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8863352)

  • 21. Immune response and vaccine efficacy.
    Afzal MA; Minor PD
    Vaccine; 1999 Apr; 17(15-16):1813. PubMed ID: 10217577
    [No Abstract]   [Full Text] [Related]  

  • 22. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples.
    Reid F; Hassan J; Irwin F; Waters A; Hall W; Connell J
    J Clin Virol; 2008 Feb; 41(2):134-7. PubMed ID: 18354822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles, mumps, and rubella antibodies in vaccinated Baltimore children.
    King JC; Lichenstein R; Feigelman S; Luna C; Permutt TJ; Patel J
    Am J Dis Child; 1993 May; 147(5):558-60. PubMed ID: 8488803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
    Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
    J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.
    Glück R; Hoskins JM; Wegmann A; Just M; Germanier R
    Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for measles-mumps-rubella vaccination in a child with prior thrombocytopenia purpura.
    Pool V; Chen R; Rhodes P
    Pediatr Infect Dis J; 1997 Apr; 16(4):423-4. PubMed ID: 9109153
    [No Abstract]   [Full Text] [Related]  

  • 28. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
    Davidkin I; Peltola H; Leinikki P; Valle M
    Vaccine; 2000 Jul; 18(27):3106-12. PubMed ID: 10856790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.
    Nakayama T; Urano T; Osano M; Nakagawa M; Maehara N; Sasaki K; Yamamura AM; Makino S
    Microbiol Immunol; 1990; 34(6):497-508. PubMed ID: 2120551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination.
    Boulianne N; De Serres G; Ratnam S; Ward BJ; Joly JR; Duval B
    Vaccine; 1995 Nov; 13(16):1611-6. PubMed ID: 8578850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An outbreak of mumps in a high school: Estimation of vaccine effectiveness. Zaragoza 2011].
    Compés-Dea C; Guimbao-Bescós J; Gaspar-Escayola JI; Lázaro-Belanche MÁ; Aznar-Brieba A
    Enferm Infecc Microbiol Clin; 2015; 33(6):385-90. PubMed ID: 25475656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study.
    Westphal DW; Eastwood A; Levy A; Davies J; Huppatz C; Gilles M; Lyttle H; Williams SA; Dowse GK
    Lancet Infect Dis; 2019 Feb; 19(2):177-184. PubMed ID: 30558994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland.
    Johnson H; Hillary IB; McQuoid G; Gilmer BA
    Vaccine; 1995 Apr; 13(6):533-7. PubMed ID: 7483773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.
    Crovari P; Gabutti G; Giammanco G; Dentico P; Moiraghi AR; Ponzio F; Soncini R
    Vaccine; 2000 Jun; 18(25):2796-803. PubMed ID: 10812221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection.
    Erdman DD; Heath JL; Watson JC; Markowitz LE; Bellini WJ
    J Med Virol; 1993 Sep; 41(1):44-8. PubMed ID: 8228936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A look back at 2 mumps outbreaks].
    Paccaud MF; Hazeghi P; Bourquin M; Maurer AM; Steiner CA; Seiler AJ; Helbling P; Zimmermann H
    Soz Praventivmed; 1995; 40(2):72-9. PubMed ID: 7747524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of measles, mumps, and rubella immunization status using oral fluid samples.
    Thieme T; Piacentini S; Davidson S; Steingart K
    JAMA; 1994 Jul; 272(3):219-21. PubMed ID: 8022041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
    JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeitsgemeinschaft.
    Matter HC; Cloetta J; Zimmermann H
    J Epidemiol Community Health; 1995 Aug; 49 Suppl 1(Suppl 1):4-8. PubMed ID: 7561669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.